The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon

Wesley A. Grimm, Jeannette S. Messer, Stephen F. Murphy, Thomas Nero, James P. Lodolce, Christopher R. Weber, Mark F. Logsdon, Sarah Bartulis, Brooke E. Sylvester, Amanda Springer, Urszula Dougherty, Timothy B. Niewold, Sonia S. Kupfer, Nathan Ellis, Dezheng Huo, Marc Bissonnette, David L. Boone

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon'. Together they form a unique fingerprint.

Medicine & Life Sciences